Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antisense oligonucleotides that modulate human HER-2 expression patented

Oct. 27, 1999

Polyamine derivatives designed at U. of Florida for reduced toxicity

Oct. 26, 1999

Novel oncological compounds acting as antagonists of protein-carbohydrate binding

Oct. 26, 1999

New antitumor diterpenes discovered in China

Oct. 26, 1999

U. of Minnesota designs anticancer, antiviral phosphoramidated nucleosides

Oct. 25, 1999

Cancer immunotherapy method available for licensing from NIH

Oct. 25, 1999

Interim phase I/II results presented for Transgene's TG-1021

Oct. 25, 1999

Sanofi-Synthelabo's platinum complex launched in second European market

Oct. 25, 1999

Phase I pharmacokinetic, pharmacodynamic and toxicological data published for ISIS-5132

Oct. 22, 1999

Breast cancer patients now being sought for Korean trials of Genexol

Oct. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...